March 12, 2015
Allergen Research Corporation Completes $80 Million Series B Financing to Advance Drug Development Portfolio for Food Allergy

January 15, 2015
ALPHAEON Corporation Closes Series A Preferred Stock Financing In A Transaction Led By Longitude Capital Management Co., LLC.

January 14, 2015
Flamel sinks on Jazz Pharma patent ruling

© 2008 Longitude Capital Management Co., LLC. All rights reserved.